×
Log in
Upload File
Most Popular
Study
Business
Design
Technology
Travel
Explore all categories
The top documents tagged [mario sznol]
Immuno-Oncology: A Colloquium on the State of the Science for Oncology Clinicians
4.974 views
Survival, response duration, and activity by BRAF mutation (MT) status of nivolumab (NIVO, anti-PD-1, BMS-936558, ONO-4538) and ipilimumab (IPI) concurrent
216 views
Presented By Mario Sznol at 2014 ASCO Annual Meeting
68 views
Yale Cancer Center CenterPoint Magazine Spring | Summer 2014
214 views
Breakthroughs > The Year in Review 2014
218 views